Successful treatment of invasive stomatitis due to exophiala dermatitidis in a patient with acute myeloid leukemia

Journal of Oral Pathology and Medicine

Volumn 32, Issue 1, 2003, Pages 51-54

  Myoken, Yoshinari ^a   Sugata, Tatsumi ^a   Fujita, Yoshinori ^a   Kyo, Tai ichi ^a   Fujihara, Megumu ^b   Katsu, Masakazu ^a   Mikami, Yuzuru ^a  

^a CHIBA UNIVERSITY   (Japan)

^b H R Cross Atom Bomb Survivors H ^*  (Japan)

Author keywords

Antifungal agents; Exophiala dermatitidis; Invasive stmatitis; Neutropenia

Indexed keywords

AMPHOTERICIN B; ENOCITABINE; IDARUBICIN; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; PREDNISOLONE; RIBOSOME DNA; TOSUFLOXACIN; VINCRISTINE; ANTIFUNGAL AGENT; FUNGAL DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL ACTIVITY; CANDIDIASIS; CASE REPORT; DISEASE COURSE; DNA SEQUENCE; DRUG ACTIVITY; DRUG SENSITIVITY; EARLY DIAGNOSIS; EXCISION; EXOPHIALA; EXOPHIALA DERMATITIDIS; FEMALE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPETENCE; IN VITRO STUDY; MOUTH INFECTION; MOUTH ULCER; NEUTROPENIA; PROTEIN DOMAIN; REVIEW; STOMATITIS; ARTICLE; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MYCOSIS; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; DNA, FUNGAL; EXOPHIALA; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INFUSIONS, INTRAVENOUS; ITRACONAZOLE; LEUKEMIA, MYELOCYTIC, ACUTE; MYCOSES; NEUTROPENIA; STOMATITIS;

EID: 0037267051     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2003.00056.x     Document Type: Review

References (11)

1. Myoken Y, Sugata T, Kyo T, et al. Invasive Aspergillus stomatitis in patients with acute leukemia: report of 12 cases. Clin Infect Dis 2001; 33: 1975-80.
2. Myoken Y, Sugata T, Kyo T, Fujihara M. Oral Fusarium infection in a granulocytopenic patient with acute myelogenous leukemia: a case report. J Oral Pathol Med 1995; 24: 237-40.
3. Uijthof JMJ, van Belkum A, de Hoog GS, Haase G. Exophiala dermatitidis and Sarcinomyces phaeomuriformis. ITS1-sequencing and nutritional physiology. Med Mycol 1998; 36: 143-51.
4. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidiumforming filamentous fungi. Proposed standard M-38 P. National Committee for Clinical Laboratory Standards, Wayne, PA, 1998.
5. Gold WL, Vellend H, Salit E, et al. Successful treatment of systemic and local infections due to Exophiala species. Clin Infect Dis 1994; 19: 339-41.
6. Rossman SN, Cernoch PL, Davis JR. Dematiaceous fungi are an increasing cause of human disease. Clin Infect Dis 1996; 22: 73-80.
7. Clancy CJ, Wingard JR, Nguyen MH. Subcutaneous phaeohyphomycosis in transplant recipients: review of the literature and demonstration of in vitro synergy between antifungal agents. Med Mycol 2000; 38: 169-75.
8. Sudduth EJ, Crumbley AJ, Farrar WE. Phaeohyphomycosis due to Exophiala species: clinical spectrum of disease in humans. Clin Infect Dis 1992; 15: 639-44.
9. Myoken Y, Sugata T, Kyo T, Fujihara M, Mikami Y. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia. J Periodontol 2002; 73: 33-8.
10. Sharkey PK, Graybill JR, Rinaldi MG, et al. Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol 1990; 23: 577-86.
11. Malik IA, Moid I, Aziz Z, Khan S, Suleman M. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia. Am J Med 1998; 105: 478-83.